Methodologic Considerations on Four Cardiovascular Interventions Trials With Contradictory Results.


Journal

The Annals of thoracic surgery
ISSN: 1552-6259
Titre abrégé: Ann Thorac Surg
Pays: Netherlands
ID NLM: 15030100R

Informations de publication

Date de publication:
02 2021
Historique:
received: 08 10 2019
revised: 13 03 2020
accepted: 24 04 2020
pubmed: 17 6 2020
medline: 13 2 2021
entrez: 17 6 2020
Statut: ppublish

Résumé

Contradictory findings from randomized trials addressing similar research questions are not uncommon in medicine. Although differing results may reflect true differences in the treatment effects or in the deliverability of the intervention, more commonly it is as a consequence of small but important discrepancies in study design. The writing group selected 4 recent trials with apparently contradictory results (2 on revascularization for left main coronary stenosis and 2 on treatment of secondary mitral regurgitation). Detailed methodologic analysis was performed to elucidate the difference in findings. Differences in the definition of the primary outcome are the most likely explanation for the contradictory findings of NOBLE versus EXCEL. Differences in study design (leading to substantially different patient populations) and in outcome definition might explain the discrepant findings of MITRA-FR versus COAPT. As shown by the comparative analysis of NOBLE and EXCEL and MITRA-FR and COAPT, changes in study design, outcome definitions, and patient population can markedly affect the outcome of randomized clinical trials.

Sections du résumé

BACKGROUND
Contradictory findings from randomized trials addressing similar research questions are not uncommon in medicine. Although differing results may reflect true differences in the treatment effects or in the deliverability of the intervention, more commonly it is as a consequence of small but important discrepancies in study design.
METHODS
The writing group selected 4 recent trials with apparently contradictory results (2 on revascularization for left main coronary stenosis and 2 on treatment of secondary mitral regurgitation). Detailed methodologic analysis was performed to elucidate the difference in findings.
RESULTS
Differences in the definition of the primary outcome are the most likely explanation for the contradictory findings of NOBLE versus EXCEL. Differences in study design (leading to substantially different patient populations) and in outcome definition might explain the discrepant findings of MITRA-FR versus COAPT.
CONCLUSIONS
As shown by the comparative analysis of NOBLE and EXCEL and MITRA-FR and COAPT, changes in study design, outcome definitions, and patient population can markedly affect the outcome of randomized clinical trials.

Identifiants

pubmed: 32540434
pii: S0003-4975(20)30911-5
doi: 10.1016/j.athoracsur.2020.04.107
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

690-699

Commentaires et corrections

Type : CommentIn

Informations de copyright

Copyright © 2021 The Society of Thoracic Surgeons. Published by Elsevier Inc. All rights reserved.

Auteurs

Mario Gaudino (M)

Department of Cardiothoracic Surgery, Weill Cornell Medicine, New York, New York. Electronic address: mfg9004@med.cornell.edu.

Marc Ruel (M)

Division of Cardiac Surgery, University of Ottawa Heart Institute, University of Ottawa, Ottawa, Ontario, Canada.

Jean-Francois Obadia (JF)

Department of Cardiovascular Surgery, Hôpital Cardiologique Louis Pradel, Lyon, France.

Michele De Bonis (M)

Department of Cardiac Surgery, IRCCS San Raffaele University Hospital, Milan, Italy.

John Puskas (J)

Department of Cardiovascular Surgery, Mount Sinai Saint Luke's, New York, New York.

Giuseppe Biondi-Zoccai (G)

Department of Medico-Surgical Sciences and Biotechnologies, Sapienza University of Rome, Latina, Italy; Mediterranea Cardiocentro, Naples, Italy.

Dominick J Angiolillo (DJ)

Division of Cardiology, University of Florida College of Medicine, Jacksonville, Florida.

Mary Charlson (M)

Department of Healthcare Policy and Research, Weill Cornell Medical College, New York, New York.

Filippo Crea (F)

Department of Cardiovascular and Thoracic Sciences, Fondazione Policlinico Gemelli-IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy.

David P Taggart (DP)

John Radcliffe Hospital, University of Oxford, Oxford, United Kingdom.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH